Hip
Senior Member
- Messages
- 18,109
I go on road and mountain bike rides now. This past weekend I did 76 miles on Saturday and 53 miles on Sunday. Over the 4th of July weekend I rode from LA to Santa Barbara and back (115 miles each way). I'm working from home full-time and volunteering. Bad days are fewer and farther between. Still have constant sore throat.
Sounds like you have more-or-less fully recovered from ME/CFS. That's great.
I wouldn't be able to say the HBOT or the hydroxychloroquine is specifically responsible for the improvement - I suspect both to some extent.
What was the reason you started taking hydroxychloroquine? As an autoimmune treatment perhaps?
In this post you say you started hydroxychloroquine (Plaquenil) in August 2018, so that is now two years you have been on this drug. From that post, it sounds like you made quite significant improvements in just the first two months on hydroxychloroquine. What hydroxychloroquine dose have you been using?
I recently speculated in this thread that hydroxychloroquine + zinc might be effective for the enterovirus infections found in ME/CFS. Supplemental zinc may be important to elicit the antiviral effects of this drug.
I've just started taking hydroxychloroquine 200 mg + zinc 50 mg daily, in the hope that this might help my enterovirus ME/CFS. So it's interesting to see that you did well on hydroxychloroquine + HBOT.
What viral infections are associated with your ME/CFS? Is just EBV?
Were you using a home soft HBOT chamber (the ones that are typically 1.3 atm pressure)?
I've considered making a separate thread to document things.
That would be great. I recently started a thread called List of ME/CFS Recovery and Improvement Stories, and it would be good to include your story in that thread.
I saw in your other posts that you were mild, bordering moderate, on the ME/CFS scale of very severe, severe, moderate, mild, remission (before your hydroxychloroquine and HBOT treatment).
So it sounds like that as a result of treatment, you made a 1½-level improvement on that scale, moving from mild/moderate to remission, over the last two years since Aug 2018.
Last edited: